[Alert] Big Pharma Caught BLOCKING Cures
Just when you thought Big Pharma and mainstream medicine couldn’t sink any lower…
A leaked report reveals the ugly truth: The health industry has no intention of curing diseases.
Why, you ask?
Money, of course.
You see, there’s little money in cures… and billions to be made from long-term medication management.
And Big Pharma’s latest shenanigans with a breakthrough therapy just proves they will do anything to protect their wallets – even if it costs millions of lives along the way.
Science is on the brink of a breakthrough – a gene therapy that could cure numerous genetic conditions by altering individual units of DNA.
This incredible development would save countless lives and spare millions the agony and pain of disease.
But the corporate overlords aren’t interested in cures.
A leaked report from Goldman Sachs analyst Salveen Richter has revealed the disturbing mentality of those that profit from our ailments.
It reads: “The potential to deliver 'one-shot cures' is one of the most attractive aspects of gene therapy, genetically-engineered cell therapy, and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies.”
Simply put, Big Pharma and its investors stand to make way more money if they offer drugs that keep us sick rather than actually cure diseases.
This type of greed is a symptom of a privatized health care system where corporations and investors stand to make billions the more people fall ill.
On the other hand, countries with public health care systems don’t benefits from disease.
Instead, these countries will reap the benefits of gene therapy and other new health tech while the U.S. is left in the dust with the same old sickening drugs.
In the leaked report, Richter uses the example of a hepatitis C drug that made Gilead Sciences $12.5 billion in 2015, alone.
But because it cures the disorder so effectively – and in only 12 weeks – profits from this drug are now below $4 billion annually.
Richter’s report concludes: “While this proposition carries tremendous value for patients and society, it could represent a challenge for… sustained cash flow.”
Can you imagine being so selfish as to reject life-saving science in favor of your own wealth?!
Unfortunately, medical breakthroughs rely on the investments made by the very clients Richter was writing to.
You see, it’s incredibly expensive to develop cures like gene therapy. Not to mention the cost of testing and trials before FDA approval.
Without a more efficient way to fund medical research, the corporate overlords are calling the shots.
What can you do to help change this backwards system?
Call your local representatives and encourage them to fund the development of new treatments past the basic research stages.
It may not happen tomorrow but every voice means we’re that much closer to changing this broken system.
Fighting For Your Health,
Executive Director, Alliance For Advanced Health